A dynamic, fast-paced biopharmaceutical company on the cutting edge of antibody discovery.

Core business

OmniAb is a biopharmaceutical company focused on assisting pharmaceutical companies to discover and develop medicines. As a leader in transgenic animal technology, OmniAb has amassed a portfolio of technologies that enable and enhance the discovery of therapeutic antibodies.

OmniAb® platform is comprised of transgenic animal assets from three different species (mouse, rat, and chicken). Each of these OmniAb animals are capable of generating high quality human-sequence antibodies upon immunization. OmniChicken was the first, and currently the only transgenic chicken with this capability. New variants are continuing to be developed at the Emeryville facility. OmniAb partners with small and large biotechnology and pharmaceutical companies to discover novel cohorts of human antibodies against specific targets.

About the company

OmniAb is headquartered in Emeryville, CA and has 143 employees. As an intern you will be working at OmniAb’s extensive antibody discovery facility in Emeryville, where their OmniAb® platform is used to provide the company partners with access to cutting-edge antibody discovery technologies.

 
Previous
Previous